MISSISSAUGA, Ontario, Aug. 07, 2025 (GLOBE NEWSWIRE) — Microbix Biosystems Inc. ( TSX: MBX, OTCQX: MBXBF, Microbix ® ), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its third quarter of fiscal 2025 ended June 30, 2025 (“ Q3 2025 ”) prior to the start of trading on August 14, 2025. At 10:00 AM ET that day, Microbix intends to hold a webinar discussion of Q3 2025 results with its CEO, CFO, and COO.

Investor and shareholders can participate in the webinar, hosted by Adelaide Capital, by registering at: https://us02web.zoom.us/webinar/register/WN_Fh7z2eGySSaC-F_w9GLKig .

It will also be live-streamed to YouTube at: https://www.youtube.com/channel/UC7

See Full Page